CLPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

ClearPoint Neuro, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026

$9.17+0.10 (+1.10%)

Close on Oct 19, 2026

Community

Notes and questions about ClearPoint Neuro from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in ClearPoint Neuro's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-40 reverse split on Aug 15, 2016
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CLPT.

Revenue growth25.9% · median 42.8%

Gross margin62.6% · median 76.6%

Operating margin-73.4% · median -61.1%

Net margin-81.8% · median -68.0%

Advertisement
300 × 250